Search for: "Michel v. Executive Office"
Results 101 - 120
of 190
Sorted by Relevance
|
Sort by Date
24 Jul 2012, 11:34 am
Van Sciver was also named Trustee, along with Jonathan and Michelle Tarter as contingent Trustees. [read post]
8 Nov 2021, 11:44 am
Or should they be disqualified from holding office in the future? [read post]
22 Oct 2009, 6:46 am
This case may be related to another DME health care fraud case, U.S. v. [read post]
13 Jul 2020, 10:00 am
TestyPresident and Chief Executive Officer, Law School Admissions Council (LSAC) Richard M. [read post]
20 Dec 2008, 3:00 am
(Class 46) Council Regulation 1229/2008 enters San Simón da Costa (PDO), Ail blanc de Lomagne (PGI), Steirischer Kren (PGI) into Register of protected designations of origin and protected geographical indications (Class 46) Court of First Instance, consolidating four appeals, annuls decisions of Board of Appeal and awards costs to Budvar in proceedings over BUD appellation: Budějovický Budvar, národní podnik v Office for… [read post]
28 Oct 2019, 1:07 pm
The task force will hear testimony from Michele Flournoy, the co-founder and managing partner of WestExec Advisors, and Jim Talent, the co-chair of the Reagan Institute Task Force. [read post]
13 May 2022, 4:00 am
National/Federal A 49-Year Crusade: Inside the movement to overturn Roe v. [read post]
8 Jan 2008, 11:59 pm
And yet this week the Supreme Court heard oral argument in Baze v. [read post]
30 Mar 2007, 1:10 am
In Morris v. [read post]
15 Mar 2018, 8:28 am
Circuit Has recently faced in the dispute between Spanski Enterprises v. [read post]
1 Feb 2019, 6:29 am
He borrowed additional reasoning from Tumey v. [read post]
10 May 2019, 4:30 am
United States v. [read post]
21 Feb 2023, 6:19 pm
Today, in American Rivers v. [read post]
29 Aug 2019, 8:29 am
Eva-Maria Herring (who in the Qualcomm v. [read post]
9 Mar 2020, 1:21 pm
Biosimilar Markets [I entered in media res]· Eva Temkin, Acting Director for Policy, Office of Therapeutic Biologics and Biosimilars, CDER, FDA · Christine Simmon, Executive Director, Biosimilars Council, AAM: barriers to entry for biosimilars: exclusionary contracts, rebates, stakeholder misinformation. misinformation can include explicit and implicit, including policies such as naming conventions and the very existence of the interchangeable… [read post]
7 Mar 2012, 9:00 am
Pramas and Michelle K. [read post]
15 Aug 2013, 8:10 am
(Pix (c) Larry Catá Backer 2013)In 2010, the faculty at Penn State Law approved the creation of a new concept course, to be named "Elements of Law". [read post]
29 May 2014, 10:50 am
The executive. [read post]
14 Jan 2011, 4:05 pm
The Stig speeds away from the BBC’s interim injunction, Nicholas Tall and Michelle Lewiston (Speechly Bircham LLP). [read post]
1 Jun 2017, 9:01 pm
Supreme Court recently decided Expressions Hair Design v. [read post]
